SubscribeSign In
LeaderPortfolio
Billionaire Profile
M
Global Rank
#2625

Image: Romanian government; scan by Biblioteca Metropolitană București | Public domain | via Wikimedia Commons

Mori Arkin

CEO, Pharmaceuticals
ISRAEL
Real-Time Net Worth
$1.517B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.03% (24h)
Age
73
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
ISRAEL

Biography

Mori Arkin is an Israeli billionaire and entrepreneur, primarily known for his significant contributions to the pharmaceutical industry. Born in 1952, Arkin's career began in 1972 assisting his father in a pharmaceutical distribution business. He transformed the family business into Agis Industries, a major player in generic pharmaceuticals. In 2005, he sold Agis to Perrigo for $390 million. Arkin then founded Arkin Holdings and Arkin Capital, a multi-stage investment manager, expanding into biotech, healthcare, and related sectors. His estimated net worth as of March 2026 is $1.5 billion. Arkin's career is marked by strategic exits, successful investments, and a commitment to philanthropic endeavors through the Arkin Family Foundation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Moshe "Mori" Arkin was born in Ramat Gan, Israel, in 1952. His parents were Russian immigrants who owned a pharmacy, which provided a modest entrepreneurial foundation. Arkin's father, Ziama Arkin, founded Agis Commercial Agencies in 1961, a pharmaceutical importer.

Rise to Success

Arkin began his career in 1972, assisting his father in their pharmaceutical distribution business. In 1983, he transformed it into Agis Industries, which became a leading generic pharmaceutical manufacturer, particularly in topical dermatological products. Arkin's strategic acumen led to the 2005 sale of Agis to Perrigo for $390 million. Following this, he established Arkin Capital in 2009, an investment platform for life sciences ventures.

Key Business Strategies

Arkin's business strategy is characterized by industry specialization, strategic exits, and reinvestment in high-growth niches. A significant move was the 2004 sale of Agis Industries, which provided capital for subsequent ventures. He retained majority ownership of Sol-Gel Technologies, a dermatology-focused firm, after its 2018 IPO, underscoring his focus on long-term value creation.

Philanthropy

Arkin, along with his wife Doris, established the Arkin Family Foundation in 2011. The foundation supports initiatives in education, arts and culture, welfare, healthcare, civil rights, and Jewish-Arab coexistence.

Career Milestones

1972

Joined Family Business

Began assisting his father in a pharmaceutical distribution company.

1983

Founded Agis Industries

Transformed the family business into a generic pharmaceutical manufacturer.

2005

Sold Agis Industries

Sold Agis to Perrigo for $390 million.

2009

Founded Arkin Capital

Established an investment firm focused on life sciences.

2018

Sol-Gel Technologies IPO

Oversaw the public offering of Sol-Gel Technologies on Nasdaq.

2011

Arkin Family Foundation

Established Arkin Family Foundation, focused on education, healthcare, civil rights, and Jewish-Arab coexistence

Philanthropy & Social Impact

Education

Ziama Arkin Parent and Infant Relations (PAIR) Institute

Undisclosed

Supported the establishment of the PAIR Institute at Reichman University, focusing on parent-infant relationships.

Compare Mori Arkin

Net Worth Face-off
Mori Arkin vs Elon Musk
Compare Wealth →
Net Worth Face-off
Mori Arkin vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Mori Arkin vs Mark Zuckerberg
Compare Wealth →